Precision medicine: Developing the next practice in cardiovascular care
Imagine we could predict your risk of heart failure.
That's the idea behind precision medicine. Precision medicine involves using advanced AI techniques to develop tools, like specialized software and apps, that help health care providers determine an individual's risk of developing health problems, precisely diagnose existing conditions and determine the best treatment.
The Libin Cardiovascular Institute is embracing precision medicine techniques with the goal of providing the next practice in cardiovascular health care. We're closer than ever to turning what we only once dreamed of into a reality.
Learn more about our Precision Medicine Initiative.
Precision Medicine Projects
Finding novel ways to treat atrial fibrillation
Research takes a step closer to precision health in clinical decision-making for atrial fibrillation. University of Calgary researcher, Dr. Derek Chew, is helping develop a new approach to treating people with the common arrhythmia.
A team of researchers, led by Dr. James White, is using artificial intelligence-based software to precisely diagnose heart muscle diseases in seconds and predict future heart complications.
Pinpointing the best time to intervene with aortic aneurysms
Vascular surgeon Dr. Randy Moore and biomedical engineer Dr. Elena Di Martino developed "game-changing" software to help determine the best time to surgically intervene in treating aortic aneurysms. The condition impacts 20,000 Canadians.
Predicting kidney disease
Researchers have developed a risk assessment tool capable of predicting whether acute kidney injury may progress to advanced chronic kidney disease to identify those who may develop kidney disease to provide follow up care and tailored treatments.
How we are using data
The Precision Medicine Initiative is developing the initial frameworks and foundation to collect and use data to develop important prediction tools. Cardiac patients may have the opportunity to consent to their data being used during their regular clinic visits for use in this work. The risk models that we develop will be implemented clinically to benefit all cardiac patients in the Calgary Zone.
The Libin Cardiovascular Institute is a joint entity of Alberta Health Services and the University of Calgary and as such is governed by the privacy policies of these institutions:
- Data obtained from AHS is released according to AHS governance standards – to learn more, visit https://www.albertahealthservices.ca/about/page121.aspx
- Data stored at the University of Calgary is secured and managed according to UofC governance standards – to learn more, visit https://research.ucalgary.ca/conduct-research/additional-resources/research-data-management